• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Italian state attorney moves to block Sorin merger with Cyberonics

Italian state attorney moves to block Sorin merger with Cyberonics

July 27, 2015 By Brad Perriello

Sorin and Cyberonics mergerAn Italian state attorney in Milan moved to block the pending, $2.7 billion merger between Sorin Group (BIT:SRN) and Cyberonics (NSDQ:CYBX), seeking to prevent Sorin from dodging a $3.76 billion environmental lawsuit filed against its former corporate parent.

Sorin and Cyberonics, which announced the merger in February, plan to re-brand the combined company as LivaNova and re-incorporate in the U.K. Sorin’s shareholder’s OK’ed the deal in May, a month after it won approval from U.S. anti-trust regulators.

Today Sorin said it plans to “vigorously contest” the move by the state’s attorney of Milan to enjoin the deal. The Italian prosecutor alleges that the merger with Cyberonics “is intended to insulate Sorin from potential liability related to pending environmental litigation” against Sorin’s former owner, SNIA SpA, which spun Sorin out in 2004. Italy’s environmental ministry is seeking €3.4 billion in damages and remediation costs for allegedly contaminated SNIA sites, according to La Repubblica.

“Sorin and Cyberonics believe the Italian state’s attorney fundamentally misunderstands and misconstrues the structure and goals of the transaction, as well as Italian and European laws and regulations governing these types of transactions. Sorin and Cyberonics believe that the allegations by the Italian state’s attorney are without merit, and Sorin intends to contest them in the Civil Court of Milan,” the companies said.

“We will vigorously contest this claim and seek expedited hearings for this purpose. In the meantime, our 2 companies’ integration plans are progressing well and will continue. At this point, the effect of the Italian state’s attorney’s claim on the timing of the closing of the transaction is unclear, however we will continue to progress towards our scheduled closing and keep both external and internal stakeholders informed of developments,” added Sorin CEO André-Michel Ballester.

The Sorin-Cyberonics merger was slated to close by the end of the 3rd quarter.

Filed Under: Cardiovascular, Legal News, Mergers & Acquisitions, Neuromodulation/Neurostimulation Tagged With: cyberonics, Sorin Group

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy